Created in 2006 (United States), DURSPONSE own 496 sister brands and 17478 competing brands. The DURSPONSE brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. The sector of DURSPONSE is Drug Manufacturers.

DURSPONSE is a brand of BRISTOL-MYERS SQUIBB COMPANY (BMY) Other brands

Buy BRISTOL-MYERS SQUIBB COMPANY share with

(0% commission and fractional shares)

Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Other brands
BRISTOL-MYERS SQUIBB COMPANY

Amira Pharmaceuticals

Cormorant Pharmaceuticals

A
- Amylin Pharmaceuticals
- AHEFCI
- ALIKLUVE
- ADVOREY
- AUREXIS
- AZENMI
- AKAZEP
- AEGEAN - Assessment of an Education and Guidance program for Eliquis Adherence in Non-valvular atrial fibrillation
- AVENUE: An Investigation and Understanding
- ACTIVJEX
- A-CLICK
- ADVANCEGRIP
- APEXAGARD
- AVEMRY
- AMNIQUIS
- AVATREUM
- ADVANCING IMMUNOTHERAPY in ONCOLOGY
- APEXIGUARD
- APEXAGUARD
- AVAXATAP
- ADNEXUS
- ABLIXTO
- APERFIT
- ADNECTIN
- ANGIOCEPT
- AGREE
- AVERROES
- APPRAISE APixaban for PRevention of Acute Ischemic Safety Events
- APixabanforPReventionofAcuteIschemicSafetyEvents
- APROPOS
- ARISTOTLE
- APPEAR
- AWAKEN
- ALSAXLO
- ARRIVE - ABATACEPT RESEARCHED IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE ANTI-TNF RESPONSE TO VALIDATE EFFECTIVENESS
- ARPIQUA
- ARZUVAD
- AIM B Avareness Intervention and Management of Chronic Hepatitis B
- AXECTITUDE
- APLURIZE
- ALERTUM
- ASIDE: A PHASE IIIB, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY AND INTRAVENOUSLY IN
- ADNEXUS THERAPEUTICS
- ALBITAL
- ACTOL
B
- BEQSTIAT
- BEXLAMDA
- BOKIQSA
- BECAUSE EACH ENDPOINT COUNTS
- Be Melanoma Smart
- BECLICK
- BILTIMET
- BRIPALO
- BRIVADEP
- BRIPOLO
- BRAPOLO
- BRIVTAGA
- BRIVTAGNA
- BAMBROVA
- BRAPOLLO
- BRIPOLLO
- BRABANTIV
- BRAPIXA
- BYTIFIC
- BALTARC
- BELOW
- Bristol-Myers Squibb Together we can prevail.
- BREGLIV
- BMS
- BMS BRISTOL-MYERS SQUIBB COMPANY
- BMS IRBESARTAN
- BANREVLA
- BELLAQUIP
- BRELCAPA
- BELTAPTA
- BRISTOL-MYERS SQUIBB TRANSFER DEVICE
- BMS VIROLOGY
- BRONCOCLAR
C
- ConvaTec Divestiture
- Cardioxyl Pharmaceuticals
- CMPASS-EU
- COBLIXRA
- CLATAZEV
- CEVRIEP
- CHECKMATE
- CIMMKEY
- CESVUNO
- CESVONO
- CHOOSE TO MAKE A DIFFERENCE
- CONTINUUM OF CARE
- CML THERAPY
- CUSTOMERS @ CENTER
- CLICKJECT
- COMFICLIQ
- COMFICLICK
- CML SCORING TOOL
- CONFIHOLD
- CONFIGLIDE
- CIPRALAN
- CARBOPHOS
- CAPLET
- CO-EFFERALGAN
- CEFALOJECT
- CEFALGAN
- CHOLOVERNIL
- CAL-C-TOSE
- Carvasept
D
- DuPont Pharmaceuticals
- DRIVIXTI
- DAKMELA
- DURLAMDA
- DACLIRCO
- DACLERAD
- DEMVEP
- DASCOVERY
- DOTHEMATOLOGY
- DUOGYZA
- DUOGYZE
- DALRADCO
- DALRADCA
- DUOGLYZE
- DAPAGLEZE
- DAPLICISE
- DURMABA
- DEFINE
- DELBAVA
- DURMABRA
- DARCELBA
- DISCOVERING THE NEXT FUTURE
- DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab
- Dermster OBERLIN
- DEXFLUID
- DATUB
- DEXIR
- DONORMYL
- DECTINIA
- Dubatol
- DIFEGASTRYL
E
- EMPLICITI
- EBLETEG
- ELZESKI
- ETOTUZE
- ENODUB
- EVOTAZ
- EVEBLY
- ETINZUE
- EMKELOS
- ELZITUDE
- epiQuid?
- E-ALL OF THE ABOVE
- EPIQUID
- ELOQUENT
- EBLICIMET
- EBYONT
- ERGOEASE
- EASYDELIVER
- ERGOGLIDE
- EASYGRASP
- ELAQUIS
- EVEMRY
- EXPANSE
- ECEVLI
- Enlite The Essential Breast Cancer Resource
- ERZELBA
- EFFERALGAN
- EFFERFRESCO
- EFFERALGIN
- Eldophyllin
- ENFALAC
F
- FYTIMRI
- FYLAMDO
- FASVYKE
- FASVYKA
- FINZECO
- FEXPONA
- FYDALIR
- FORSYNZIG
- FULLCLICK
- FIMITAR
- FULGLYZA
- FAREVLA
- FERVEX
- FOSITENS
- FLAMUTIL
- FLUNIR
G
- GENCLICK
- gluality once a day
- gluality xr once a day
- GEMETEM
- GLYZAMET
- GLIZAMET
- GOBRIVNA
- GLESIBLIS
- GLUALITY
- GREXLO
- GOVOMNI
- GASTRALGINE
- GASTRALGIN
H
- HESVOCA
- HEART BEAT
- HYDROCEL
- Hydrosept
I
- iPierian
- INTUISTEP
- IMFAZRA
- IMSTRATUS
- IMMVIVUR
- IMREJUV
- IMVIVOR
- IMREVITE
- I-O International Immuno-Oncology Network
- I O
- I-O INTELLIGENCE
- IDEATE: IPILIMUMAB DRUG EVALUATION
- It'sBestToTest
- IXEMPRA
- IMSYSREV
- IMTELGA
- IMSYSTREV
- IMROBUS
- IMREVLA
- INHIBITEX
- ING. ROQUE LEON
- Intestin-Euvernil
J
- JEQUED
- JUSTCLICK
- JORSMA
- JASERAN
- JEZRET
K
- KOBLAX
L
- LCEPDA
- LAMNETIQ
- LAMNETIK
- LAMNETIC
- LAMBACEP
- LAMDACEP
- LIFAZRA
- LAMDIFRA
- LIMTROZ
- LELTUX
- LELTUZA
- LYGZAMET
- LYGLAMET
- LAVIZENT
- LOJINU
- LOGINU
- LOGINOUS
- LIVSURVA
- LONGLYZA
- LATASUV
- LATRABA
- LELTUZIQ
- LICTINE
- LOFENALAC
M
- MAZARAY
- MAZAREY
- MMIQELOX
- MLUMIQ
- MVOKIS
- MKIXYM
- MELANOMA EXPOSED
- MY CML LIFE Living Confidently with CML
- MY CML LIFE
- METYOND
- METNITI
- MEFGLYA
- MIAVDA
- MASURVO
- MSCRAMM
- MOVIBEN
- MANTADIX
- Momentol
N
- NIMLAMBA
- NISPIRTO
- NIVOCUS
- NIVDIREC
- NUELOJIX
- NUELOGIC
- NUOLOGIC
- NEXTUBIN
- NULOJIC
- NULOJIX
- NULOJX
- NUVALOJIC
- NUVOLOJIX
- NUVALOJIX
- NIFLUMYL
- NORMODOXYL
O
- OBREFCO
- ORKEPA
- OPDIVO
- OPD1VO
- OPDETA
- OPDYTA
- OTAC ONCOLOGY TUMOR ADVISORY COUNCIL
- OPTI-MONITOR Knowledge and tools for optimal care
- OPTI-MONITOR
- ORZINDO
- ORENCIA SIMPLEGRIP
- ORENCIA SECUREGRIP
- ORENCIA ADVANCEGRIP
- ORENCIA ERGOEASE
- ORENCIA SIMPLEGLIDE
- ORENCIA EASYGRASP
- ORENCIA CONFIHOLD
- ORENCIA CONFIGLIDE
- ORENCIA TAILORGRIP
- ORENCIA EASYDELIVER
- ONOSERAMET
- ORBRODA
- ONGLAMET
- ONGLIMET
- ONGLYZA PLUS MET
- ONGLYZA + MET
- ONGLYMET
- ORTUNIT
- ORENCIA ZENGRIP
- ORENCIA SURESPRING
- ORENCIA SWIFTDOSE
- ORENCIA GLISSADER
- ORENCIA FEATHERJET
- ORENCIA FEATHERJECT
- ORENCIA FEATHERFIT
- ORENCIA COMFORTDOSE
- ORENCIA DEXIGN
- ORENCIA COMFORTSHOT
- ORENCIA SPRINGJECT
- ORENCIA DIRECTJECT
- ORENCIA EFFORTEASE
- ORENCIA
- Oncology Innovation Interchange
- ONGLIP
- ONGLIPA
- ORENCIA See what's possible
- ORZIPTA
- OMNORTA
- ORSPECTA
- ORZULTI
- OMAXIT
P
- Padlock Therapeutics
- PARTNERING FOR CURE
- PATH C
- PATH B
- PLYCASP
- POBRIVNA
- PRIZMETIS
- PIXAB
- PIXTRUZA
- PLESAPIX
- PARCOURS-OA
- PROFUSION
- PRO-EFFERALGAN
- PREFAGYL
- PHYTOCALM
- POLYTONYL
- PRODAFALGAN
Q
- QUTOUCH
- QUETOUCH
- Q-TOUCH
- QUVIDRA
R
- REYPOINT
- REYDUO
- RETTIVO
- RALDAPSA
- RELFUGA
- RENGLIDRI
- REMGLUFA
- RALDAPSI
- RILFUGA
- RINBOSA
- RETIGMO
- REVIPIC
- REALM
- REVIA
- REXTRIGA
- REVEPIC
- REXPONDA
- RALCEPA
- RENZOPA
- RESHAPING PROTEIN THERAPEUTICS
- REDUPSAN
S
- SIMPLISERT
- SLAMUNITI
- SUZEMO
- SUNVEPZI
- SIGDUO
- SIMPLEGRIP
- SIMPLEGLIDE
- SAXXAVIBE
- SAXAVIBE
- SOGLUXOS
- SAXAMETRA
- SAXXIVIBE
- SAXIVIBE
- STANDING STRONG AGAINST RESISTANCE
- STRENTARGA
- SYNXABA
- STRENTAARGA
- SABLIXTO
- SAXIMETRA
- STRENTUBA
- SPRYZEL
- STRENCARA
- SPRIZEL
- STRENKARA
- SPRICEL
- SPRICELL
- SEE WHAT'S POSSIBLE
- SEVER'ALGIA
- SOLUPSA
T
- TUZELOT
- TRANSPLANTPOINT.COM
- TEMBRAV
- TAILORGRIP
- TAXOL
- TRUBILITY
- TOGETHER WE CAN PREVAIL
- TASPREV
- TRUGARV
- TORGLAD
- TAXANE JOURNAL
- TOXAC
- TEPESCOHUITE
- THYMOZEPAN
U
- UPL
- UZANTEV
- UTARGZA
- UMETFI
- UPFEN
- UPSAVIT
- UPSANYLA
- UPSAPHOS
- UPSAMEDICA
- UPSAGYL
- UPSIBER 74
- UPSIBAMOL
- Upsal
- UPSALGIN
V
- VALZORAY
- VALZOREY
- VEPCEEG
- VIGLAFET
- VICTRUVA
- VEMPOZI
- VINCEnT ( VINflunine Cisplatin inEligible Trial )
- VIP Vulnerability Index Program
- V-PICT
- VIRO@CADEMY
- VIROSEM
- VIDEX
- VAGRAN
W
- WINGLORE
- WIMBLIS
- WILPROTA
- WILPRODA
X
- XIMENCY
- XEMMELOT
- XEELOMMIQ
- XELMMIQ
- XILTUZA
- XOGALPA
- XILNEK
- XIGAFUZE
- XOGLYXO
- XIPIVIX
- XOETRY
Y
- YERVOY
- YANZIBIV
- YANBRIVNA
- YANVIBNA
- YANCAV
Z
- ZATAREY
- ZIMDIVI
- ZAMLIFID
- ZUNAMIK
- ZECDELO
- ZULTEMRI
- ZOTUZIF
- ZARPOINT
- ZIPIVY
- ZIBNAVIB
- ZOBLIXTO
- ZENSPERE
- ZERIT

DURSPONSE is a brand of BRISTOL-MYERS SQUIBB COMPANY (BMY) Other brands

Other brands BRISTOL-MYERS SQUIBB COMPANY

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Other brands
BRISTOL-MYERS SQUIBB COMPANY